Posts Tagged ‘OIRM’

Bench to Bedside for Biotherapeutics (B3) workshop: Translating science into the clinic

Author: Guest, 10/18/17

Shreya Shukla is a Development Scientist at CCRM. Her scientific interests lie at the intersection of T cell immunotherapy, gene editing and stem cell bioengineering. Shreya obtained her BSc in Biomedical Engineering from Georgia Institute of Technology and PhD from Dr. Peter Zandstra’s laboratory at University of Toronto (UofT) focusing on the scalable generation of…Read more

Right Turn: These three videos show why we should be impressed by our young stem cell researchers

Author: Lisa Willemse, 11/18/16

Stroke, lung damage and mathematical modeling. You may not think these three topics have much in common and for the most part you’d be right. But they have more than one common link. First, each is either a disease focus or methodology within stem cell research. Secondly, each subject –biomaterials to aid stem cell engraftment…Read more

A complete (re)program to recognize the 10-year anniversary of iPSCs

Author: Stacey Johnson, 08/25/16

Ten years ago today, Japanese scientists Shinya Yamanaka and Kazutoshi Takahashi published a paper announcing the creation of rodent induced pluripotent stem (iPS) cells, thus pioneering the field of iPS cell technology. They showed that they could convert adult cells into pluripotent stem cells – in other words, they reprogrammed them to look and function…Read more

Right Turn: On the right track to health and prosperity

Author: Stacey Johnson, 05/27/16

The subway map is a popular metaphor for showing how to get from point A to point B with many stops along the way. It can be simple, with only a few intersecting lines of tracks – Toronto’s (shockingly inadequate) two-line system comes to mind – or complicated, like Beijing and New York City, to…Read more

Right Turn: Autism stem cell research could use a boost

Author: Stacey Johnson, 04/22/16

While I’m sure news about autism spikes in April during the annual awareness campaign, I doubt autism is absent from the news very often. Whether parents and advocates are lobbying for more services and funding, experts and non-experts are arguing over whether vaccines cause autism or celebrities are jumping onto the awareness bandwagon, it seems…Read more

Series: Spotlight on Cell Therapy

Author: Nicole Forgione, 02/17/16

Cell therapy is not a new idea. Bone marrow transplantation—the first ever cell therapy—has been around since the 1950s. Over half a century of research has brought important advancements, yet this technology has struggled to make it to prime time. Understandably, there is scepticism about whether cell therapy will live up to the hype. Recently,…Read more

Right Turn Special Report: Competition rife in Canada

Author: Stacey Johnson, 12/25/15

This may come as a shock to many of you, but the land of lakes, trees, socialism and universal healthcare has a dark underbelly: the competitive nature of its academics. If you look to the regenerative medicine community, everything looks hunky-dory and, on the surface, very collaborative; after all, the Stem Cell Network is behind…Read more

Right Turn: Moving RM discoveries to the market, in Ontario

Author: Stacey Johnson, 06/19/15

.Today is a big day for the regenerative medicine (RM) community in Ontario, Canada. Minister of Research and Innovation, Reza Moridi, just announced that the Ontario Institute for Regenerative Medicine (OIRM) will receive a new $25 million commitment* (in addition to the $3.1 million committed in November 2014) to invest in translational research for degenerative…Read more

Stem cells as the road to repairing Multiple Sclerosis

Author: Lisa Willemse, 06/02/15

. A clinical trial set to begin this month in Ottawa will test the safety and efficacy of mesenchymal stem cells to stimulate repair of damaged nerves in MS patients. This article was published simultaneously on the Ontario Institute for Regenerative Medicine website. On any given day at the general campus of The Ottawa Hospital,…Read more

Right Turn: Why Janet Rossant is optimistic about the future of regenerative medicine

Author: Stacey Johnson, 02/20/15

. If you haven’t heard the name Janet Rossant, my guess is that you aren’t part of the stem cell community or you spend a little too much time in the lab. Dr. Rossant is Chief of Research at the Hospital for Sick Children in Toronto, Canada and she leads the new Ontario Institute for…Read more